Biotechnology News

November 28, 2012

CLEVELAND--(BUSINESS WIRE)--Radisphere announced that South Fulton Medical Center in East Point, Georgia has renewed its contract for exclusive radiology services through 2013. Financial terms were not disclosed.

November 28, 2012

BEND, Ore. & SEATTLE & NEWARK, Del.--(BUSINESS WIRE)--Bend Research Inc., PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announce the development of a new technology for the production of thermostable vaccines....

November 28, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--NanoBio announced the closing of an $11 million Series C financing.

November 28, 2012

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM) today announced that the Japanese patent office has issued a key patent covering CEL-SCI’s investigational cancer drug, Multikine (Leukocyte Interleukin, Injection)*. The patent,...

November 28, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using...

November 28, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today announced that Craig Tuttle, Chief Executive Officer of Transgenomic, will be presenting at the Canaccord Genuity Medical Technology & Diagnostics Forum on Tuesday, December...

November 28, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. rheumatologists report that Amgen/Pfizer/Takeda’s Enbrel is their...

November 28, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group and AMR in their TreatmentTrends®: MRSA and Serious Gram-Positive Infections (EU) report, which includes research with over 200 infectious diseases and critical care specialists, find that the...

November 28, 2012

GENEVA--(BUSINESS WIRE)--NovImmune initiated dosing in a Phase I clinical trial of NI-0101, a first-in-class monoclonal antibody drug candidate targeting toll-like receptor-4 (TLR4) for autoimmune and inflammatory diseases.

November 28, 2012

TAMPA, Fla.--(BUSINESS WIRE)--Griffin Securities initiates research coverage on Oragenics

November 28, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (OTC QB: SNTI) announced today that two SNS01-T abstracts have been accepted for presentation at the 54th American Society of Hematology (ASH) Annual...

November 28, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC or the “Company”), a leader in the field of regenerative medicine, today announced treatment of three additional patients in the company’s two U.S. trials...

November 28, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced its presentations at an upcoming investor conference and at the 54th American Society of Hematology (ASH) annual meeting will be webcast live and will be available...

November 28, 2012

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals Announces Results from Open-Label Study for ATX-101

November 28, 2012

LAKE FOREST, Calif.--(BUSINESS WIRE)--Cryoport, Inc. (OTCBB: CYRX) today announced that Chief Executive Officer Jerrell Shelton is scheduled to present to investors at the 5th Annual LD Micro Growth Conference on Thursday, December 6, 2012 at...

November 28, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best-in-class oncology and central nervous system (CNS) therapeutics, today announced that Teva...

November 28, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical Announces CE Mark Approval of Assura Family of Implantable Defibrillators Including New Quadripolar Device

November 28, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the Oppenheimer 23rd Annual Healthcare Conference on Thursday, December 13 at 1:35 p.m. (EST) in New York. The presentation will be webcast...

November 28, 2012

CHICAGO--(BUSINESS WIRE)--At RSNA 2012, GE Healthcare continued to lead the way in dose-reduction with an agreement with the purpose of providing physicians with more tools to optimize radiation dose.

November 28, 2012

TORONTO--(BUSINESS WIRE)--A recovering European economy combined with an increasing demand for minimally invasive surgery will lead to significant growth in the European market for surgical navigation systems through 2017.

November 28, 2012

CINCINNATI--(BUSINESS WIRE)--Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of SensiFAST Genotyping Kit, which has been specifically developed for the...

November 28, 2012

BARCELONA, Spain & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that the European Commission has granted marketing authorization to Constella® (linaclotide 290mcg...

November 28, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: - 4th quarter results 2012 and preliminary annual result for 2012: 27 February 2013 - 1st quarter results 2013: 15 May 2013 - Annual General Meeting: 23 May 2013 - 2nd quarter results 2013: 23...

November 28, 2012

BASEL, Switzerland--(BUSINESS WIRE)--Windhover Information has named Okairos as one of its Top Projects to Watch at the 4th Annual Therapeutic Area Partnerships, which takes place in Boston, MA from 28-30 November 2012

November 28, 2012

NEW YORK & BUDAPEST, Hungary--(BUSINESS WIRE)--Forest Laboratories, Inc., (NYSE: FRX) and Gedeon Richter Plc. announced that Forest has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for cariprazine, a...

November 28, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--Selecta Biosciences has entered into a strategic global collaboration with Sanofi to discover highly targeted, antigen-specific immunotherapies for life-threatening allergies.

November 27, 2012

DENVER & ATLANTA--(BUSINESS WIRE)--The Global Down Syndrome Foundation and the National Down Syndrome Congress have announced distribution agreements for the hallmark Down Syndrome Prenatal Testing Pamphlet that provides current, accurate...

November 27, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bracco Diagnostics Inc. (BDI) is voluntarily initiating a Class I recall of nine (9) lots of Isovue® (iopamidol injection) Pre-Filled Power Injector Syringes (Isovue PFS, to be used in combination with Stellant®...

November 27, 2012

SEATTLE--(BUSINESS WIRE)--November 27, 2012--Dendreon Corporation (Nasdaq:DNDN) today announced that management will present at the following conferences: 2012 dbAccess BioFEST in Boston, MA, on December 4, 2012, at 2:15 p.m. ET 31st Annual J.P....

November 27, 2012

PHILADELPHIA--(BUSINESS WIRE)--Chemtura Corporation (NYSE/EuroNext Paris: CHMT) today announced that Stephen Forsyth, Executive Vice President and Chief Financial Officer, will present at the Bank of America Merrill Lynch 2012 Leverage Finance...

November 27, 2012

VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics announced today that the waterproof Neptune sound processor has passed rigorous internal testing and is now warranted for use in oceans, lakes and rivers.

November 27, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) today announced that it has enrolled the first patient in a Phase 2 clinical trial of ELND005 (Study AG201) for the treatment of agitation/aggression in patients with moderate to severe...

November 27, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission has granted marketing authorization for two new indications for once-daily Viread® (tenofovir disoproxil fumarate). The first...

November 27, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the 2012 Deutsche Bank BioFEST Conference in Boston on Tuesday, December 4, 2012 at 10:10 a.m. ET. The presentation will be available as a live webcast...

November 27, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Deutsche Bank 2012 dbAccess BioFEST on Monday, December 3...

November 27, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, today announced that the Board of Directors has increased the company's quarterly dividend to $0.43 per outstanding share of the company's common...

November 27, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--RedHill Biopharma Ltd. (TASE:RDHL), an Israeli biopharmaceutical company focusing primarily on acquisition and development of late clinical-stage, patent-protected, new formulations and combinations of existing...

November 27, 2012

WASHINGTON--(BUSINESS WIRE)--Now in its fifteenth year, the BIO CEO & Investor Conference, hosted by BIO, is the largest independent investor conference focused on publicly-traded biotechnology companies.

November 27, 2012

LONDON--(BUSINESS WIRE)--Edison has today published a comprehensive report titled Bruised but not done, examining the investment merits of ArQule, focusing on the potential of its lead program, tivantinib.

November 27, 2012

NORTHRIDGE, Calif.--(BUSINESS WIRE)--Gamma Medica, Inc. is developing biopsy capability for its LumaGEM® Molecular Breast Imaging (MBI) System. Easy to use, software calculates depth, allows multiple biopsy, immediate confirmation.

November 27, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host an Analyst Day in New York City on Tuesday, December 4, 2012 from 10:15 a.m. to 12:00 p.m. Eastern Time (7:15 a.m. to 9:00 a.m. Pacific Time) at the...

November 27, 2012

ROCHESTER, N.Y.--(BUSINESS WIRE)--ACM Global Central Laboratory has expanded its clinical trials testing services in Europe with a larger, state-of-the art central lab facility

November 27, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the launch of LifeMap Discovery™ (discovery.lifemapsc.com), a state-of-the-art roadmap of embryonic development and stem cell...

November 27, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that while very few changes in practice patterns have been made thus far in anticipation...

November 27, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--In the United States, 59% of companies surveyed by Cutting Edge Information said that they assign a dedicated budget to health economics and outcomes research (HEOR).

November 27, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that members of its executive management are scheduled to present at the 2012...

November 27, 2012

SAN MARINO, Calif.--(BUSINESS WIRE)--Shareholder Letter discusses Name Change, Corp Restructure & Significant milestone in Phase 1 physician-initiated clinical trial for ovarian cancer